|
|
Anavex raises $1.575 million
Sources News Release
http://www.sources.com/Releases/NR1363.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written: 11/07/2011
Year Published: 2011
Resource Type: Article
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that it has raised US$1,575,000.00 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73 the company’s lead drug candidate
Abstract: Hoboken, NJ – July 11, 2011 -- Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) is pleased to announce that it has raised $1,575,000 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73, the company’s lead drug candidate for Alzheimer’s disease, to advance other compounds in the Anavex pipeline, and for general corporate purposes.
"Anavex appreciates the continued support of its shareholders. The warrant exercise was an ideal way for u...
To read the full release go to http://www.sources.com/Releases/NR1363.htm
Topics
|
AlterLinks
c/o Sources
© 2023.
|
|
|
|
